Back to Directory

Marianna Smith

Email

masmith@frontierscience.org

Phone

716-834-0900 x7361

Institution

Frontier Science Foundation

Address

Frontier Science Foundation
4033 Maple Road
Amherst, NY 14226-1056
USA

Request an Update

Affiliated Studies

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

Closed to Accrual

IMPAACT 2041: Phase I/II Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women with Hepatitis C with and without HIV

DAIDS Number

Research Area

Study Status

IMPAACT 2034: Phase 1 Study of the Pharmacokinetics, Safety, and Acceptability of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children with Rifampicin-Resistant Tuberculosis

DAIDS Number

Research Area

Study Status

IMPAACT 2044: Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy

DAIDS Number

Research Area

Study Status

IMPAACT 2048/HVTN 145: Phase I Study of the Safety and Pharmacokinetics of VRC07-523LS, ePGT121v1-LS, and PDGM1400LS Alone and in Combination in Breastfeeding Infants.

DAIDS Number

Research Area

Study Status